Journal of Postgenomics: Drug & Biomarker Development
Journal of Postgenomics: Drug & Biomarker Development
Biomarkers are becoming a vital and indispensable part of clinical development. The importance of drug and biomarker development is to improve decision making, accelerate drug designing and reduce development costs mainly focusing on post-genomic processes.
Open Access
Journal of Postgenomics: Drug & Biomarker Development (JPDBD) under the open access category provides a wide range of freely available online journals, review articles and research articles in the field of clinical, medical, biotechnological, pharmaceutical and other related life science areas.
Objectives
Journal of Postgenomics: Drug & Biomarker Development (JPDBD) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of drug based biomarkers and their potential and actual applications in post genomic studies.
Editorial Manager
JPDBD is using online manuscript submission, review and tracking systems of Editorial Manager® for quality and quick review processing. Review processing is performed by the editorial board members of JPDBD or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.
International Prospectives
Since JPDBD publishes original full-length, short research articles and reviews on biomarkers in clinical, medical and pharmaceutical research, it is very much useful for academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.
Applying for a waiver or discount please e-mail(info@omicsonline.org) to the managing editor with proposed title and abstract.
Journal of Postgenomics: Drug & Biomarker Development
